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ABSTRACT
We have studied Golgi apparatus dynamics during mouse oo-
cyte in vitro maturation, employing both live imaging with the
fluorescent lipid BODIPY-ceramide and immunocytochemistry
using several specific markers (b-COP, giantin, and TGN38). In
germinal vesicle oocytes the Golgi consisted of a series of struc-
tures, possibly cisternal stacks, dispersed in the ooplasm, but
slightly more concentrated in the interior than at the cortex. A
similar pattern was detected in rhesus monkey germinal vesicle
oocytes. These ‘‘mini-Golgis’’ were functionally active because
they were reversibly disrupted by the membrane trafficking in-
hibitor brefeldin A. However, the drug had no visible effect if
the oocytes had been previously microinjected with GTP-g-S.
During in vitro maturation the large Golgi apparatus structures
fragmented at germinal vesicle breakdown, and dispersed hom-
ogenously throughout the ooplasm, remaining in a fragmented
state in metaphase-II oocytes. Similarly to what has been re-
ported using protein synthesis inhibitors, the presence of bre-
feldin A blocked maturation at the germinal vesicle breakdown
stage before the assembly of the metaphase-I spindle. These re-
sults suggest that progression of murine oocyte maturation may
require functional membrane trafficking.
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INTRODUCTION
In sexually mature mice, fully grown oocytes resume
meiosis and complete the first meiotic reductive division
just before ovulation. Resumption of meiosis can be me-
diated in vivo by a hormonal stimulus or it can take place
in vitro simply by oocytes being released from their ovarian
follicle into a suitable medium. Meiotic maturation is char-
acterized by dissolution of the nuclear membrane of the
oocyte germinal vesicle (GV) (a process known as germinal
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vesicle breakdown; GVBD), condensation of chromatin
into bivalents, chromosome alignment in the metaphase I
spindle (MET I), and separation of homologous chromo-
somes. These events are followed by emission of the first
polar body and arrest of meiosis with the chromosomes
aligned at the metaphase II spindle. Protein synthesis varies
throughout this period [1], and protein synthesis inhibitors
block spontaneous mouse oocyte in vitro maturation (IVM),
although inhibition takes place only at the GVBD stage [2–
5]. This block is characteristic of rodent oocytes because
oocytes from domestic species (cows, pigs, and sheep) re-
quire the production of novel proteins to initiate maturation,
and progress beyond the GV stage [6–9]. At the molecular
level, meiotic maturation is controlled through the activa-
tion of M-phase promoting factor (MPF), which is regulat-
ed, in turn, by the synthesis and degradation of its regula-
tory subunit, cyclin B [10–13]. In mouse occytes, cyclin B
reaches its maximum level at the end of the first M phase,
it is degraded at the time of first polar body extrusion, and
is synthesized again to prepare the oocyte for the second
meiotic division [11, 12]. Inhibition of protein synthesis
blocks rodent oocyte IVM at the GVBD stage because a
pool of preexisting cyclin B is available to reinitiate mei-
osis; however, the inability to synthesize new cyclin B pre-
vents the oocyte from progressing further [12–14].
Although much is known about the molecular switches
required for the triggering of IVM, membrane trafficking,
which is an important feature of eukaryotic cells, involving
intraorganelle shuttling of material packaged in transport
vesicles, has received little attention in oocyte maturation
studies. However, some information is available on organ-
elle dynamics, particularly at the structural level [15–20].
Once oocyte growth has begun, a single Golgi apparatus is
no longer visible, but many Golgi stacks appear in the oo-
plasm [15, 16]. These stacks are then fragmented, and re-
main in that form in oocytes arrested at metaphase II [15,
21, 22]. It is also well known that the Golgi apparatus un-
dergoes extensive fragmentation when somatic cells enter
mitosis [23–25]. This fragmentation can be mimicked by
incubating the cells with a microtubule-disrupting drug
such as nocodazole [26]; nonetheless, whether these two
phenomena are equivalent is still under debate.
In this work we have focused our attention on the Golgi
apparatus of mouse GV oocytes, as well as on the dynamics
of this organelle during murine oocyte IVM. The Golgi
apparatus plays a central role in many intracellular traffick-
ing events; both related to protein synthesis and delivery
and to processing of molecules internalized via the endo-
cytic pathway [27–32]. To probe Golgi activity we have
relied on both vital labeling and immunofluorescence, and
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we have employed the fungal metabolite brefeldin A, a
drug that inhibits protein secretion by blocking membrane
trafficking from the endoplasmic reticulum (ER) to the Gol-
gi apparatus [33]. Specifically, brefeldin A inhibits the for-
mation of a specific type of vesicular carrier that partici-
pates in anterograde/retrograde membrane transport in the
ER and Golgi. These vesicles are coated with a nonclathrin
coatomer, which is formed from several subunits of coat
proteins, and are thus known as COPI-vesicles [28, 33, 34].
As a result, the well-defined Golgi apparatus is dispersed
throughout the cytoplasm, possibly being redistributed to
the ER, both in somatic and spermatogenic cells [28, 33,
35, 36]. Brefeldin A sensitivity can thus be used to assess
the state of the Golgi apparatus as well as ER-Golgi vesic-
ular transport in a given cell.
MATERIALS AND METHODS
Chemicals and Antibodies
All chemicals were obtained from Sigma Chemical Company (St. Lou-
is, MO) unless otherwise stated. Rabbit polyclonal antibodies against
Giantin were a kind gift from Dr. Edward K.L. Chan of The Scripps
Institute, La Jolla, CA. Antibodies against TGN38 and b-COP were from
Affinity Bioreagents Inc. (Golden, CO). The monoclonal antibody
mAb414 (BabCo, Berkeley, CA) was used to detect nuclear pore com-
plexes [37].
Isolation of Mouse GV Oocytes and IVM
Female ICR mice were stimulated i.p. with 5 IU of eCG 48 h before
their ovaries were collected. Denuded GV-stage oocytes were obtained by
dissecting the ovaries into warm M2 culture medium [38] supplemented
with 100 mg/ml dibutyrylcyclic AMP (dbcAMP) to prevent GVBD, as
described [2, 20, 39]. Cumulus cells were removed mechanically, and only
intact, well-defined GV oocytes were used. The oocytes were distributed
in groups of about 10, placed in medium droplets under mineral oil, and
cultured at 378C in an incubator. Media composition and incubation times
varied with the experimental purpose (see Results). An energy-depleted
version of the M2 culture medium was also developed. For this purpose,
glucose was substituted with deoxyglucose, sodium azide was added
(0.05% w/v), and sodium pyruvate and sodium lactate were removed from
the medium. To maintain osmolarity, NaCl and KCl concentrations were
increased so that the NaCl:KCl ratio of 20:1, which was present in the
original medium, was retained. For IVM experiments the oocytes were
washed out of dbcAMP, placed in droplets of fresh M2 medium, and in-
cubated overnight. Oocytes were checked for GVBD 1–3 h after the trig-
gering of IVM [2, 39]. Completion of IVM was assessed the following
morning by first polar body extrusion (metaphase II or first polar body
oocytes). IVM was also confirmed by immunocytochemistry. The features
monitored included the formation of a metaphase II spindle, and the pres-
ence of a cortical granule-free area surrounding the spindle. For control
purposes, IVM first polar body oocytes were activated with 5% ethanol,
and activation was assessed by second polar body extrusion, pronuclear
formation, and changes in cortical granules.
Isolation of Rhesus Monkey GV Oocytes
Rhesus macaque (Macaca mullata) GV oocytes were obtained from
females exhibiting normal menstrual cycles, and which had been hyper-
stimulated by a regimen of exogenous gonadotropic hormones, as de-
scribed in detail elsewhere [40]. Oocytes were collected by follicular as-
piration using laparoscopy, and GV oocytes were selected and processed
for immunocytochemistry (see below).
Live Imaging of Golgi Apparatus
The zona pellucida of mouse GV oocytes was removed by a short
incubation in acid Tyrode medium, and the naked oocytes were placed in
dbcAMP-supplemented M2 medium containing 5 mM of the fluorescent
lipid BODIPY FL-C5-ceramide (Molecular Probes, Eugene, OR) and in-
cubated in the dark for 2 h [35, 36, 41]. The oocytes were then washed
in fresh dbcAMP-supplemented M2, incubated for an additional 0.5–1 h,
and visualized by epifluorescence microscopy using a Zeiss Axiophot
(Carl Zeiss, Thornwood, NY) or a Nikon Eclipse E1000 (Nikon, Melville,
NY) epifluorescence-equipped microscope operated with Metamorph soft-
ware (Universal Imaging, West Chester, PA).
Microinjection of Mouse GV Oocytes
Immature mouse oocytes at the GV stage were obtained as described
above. Fully grown oocytes were maintained in dbcAMP-containing M2
medium. Immature oocyte volume was calculated, and a maximum of 5%
of the egg volume was injected. Micropipettes were calibrated and front-
loaded with a solution of GTP-g-S prepared in M2 medium. Calculating
the dilution inside the oocyte, the final concentration of GTP-g-S in the
ooplasm was estimated to be 40 mM. In order to make sure the microin-
jection procedure was successful, GTP-g-S was coinjected with Texas
Red-labeled BSA (Molecular Probes). In addition, for control purposes,
one group of oocytes was injected with Texas Red-BSA alone. The sur-
vival rate of injected oocytes was 50%–60%, both for experimental and
control (injection of Texas Red-BSA alone) groups, and only intact oo-
cytes were used for experiments. Following GTP-g-S microinjection, the
oocytes were returned to dbcAMP-containing M2 medium, exposed to
brefeldin A, and processed for immunocytochemistry as described below.
Brefeldin A Treatment
Oocytes arrested at the GV stage were placed in dbcAMP-containing
M2 medium with varying concentrations (see Results) of the fungal me-
tabolite brefeldin A (Epicentre Technologies, Madison WI) and incubated
at 378C for 20 min to 1 h. In some cases oocytes were fixed following
brefeldin A treatment and processed for immunocytochemistry as de-
scribed below. In other experiments the drug was washed out, and the
oocytes were placed in fresh dbcAMP-containing M2, and further incu-
bated for 1 h at 378C. In vitro maturation experiments were also performed
in the presence of varying concentrations of brefeldin A (see Results).
Statistical analysis was carried out using the Student-Newman-Keuls, or
the Tukey-Kramer, multiple comparisons tests.
Immunocytochemistry
For immunocytochemistry the zona pellucida of mouse and rhesus oo-
cytes was removed by a short incubation in acid Tyrode medium, and the
oocytes were gently attached to poly-L-lysine-coated coverslips in calci-
um-free medium. Fixation was carried out by adding 2% formaldehyde,
followed by a 1- to 2-h incubation. The samples were then permeabilized
for 60 min in PBS containing 1% Triton X-100, and nonspecific reactions
were blocked by further incubation in PBS containing 2 mg/ml BSA and
100 mM glycine. For labeling, the antibodies were solubilized in this
blocking solution and incubated with the coverslips for 1–2 h at the ap-
propriate dilutions. After extensive washing in PBS containing 0.1% Triton
X-100, the samples were sequentially labeled with either TRITC-conju-
gated or fluorescein isothiocyanate (FITC)-conjugated (Zymed, San Fran-
cisco, CA), or Alexa-488 or Alexa-568 (Molecular Probes) appropriate
secondary antibodies for 1 h, and the DNA stain 49-69-diamino-2-pheny-
lindole (DAPI; Molecular Probes) for 5 min. For cortical granule labeling
oocytes were incubated for 1 h with a 10-mg/ml solution of FITC-tagged
Lens culinaris agglutinin (LCA-FITC; EY Laboratories, San Mateo, CA),
as reported previously [42]. Following these incubations, coverslips were
mounted in VectaShield mounting medium (Vector Laboratories, Burlin-
game, CA) and sealed with nail polish. Samples were examined with a
Zeiss Axiophot or a Nikon Eclipse E1000 epifluorescence-equipped mi-
croscope operated with Metamorph software. Confocal imaging was car-
ried out with a Leica TCS NT confocal microscope (Leica Microsystems,
Bannockburn, IL).
RESULTS
Imaging the Golgi Apparatus in Mouse GV Oocytes
Using the fluorescent Golgi-specific lipid BODIPY-cer-
amide we were able to visualize the Golgi apparatus in live
GV oocytes, arrested in dbcAMP-containing M2 medium
(Fig. 1). Laser scanning microscopy of GV oocytes labeled
with BODIPY-ceramide revealed a number of independent
structures that were either sausage-shaped or amorphous.
The labeling was reminiscent of the dispersion of Golgi
fragments throughout the cytoplasm that takes place in so-
matic cells following nocodazole treatment [26]. These
stacks, or ‘‘mini-Golgis,’’ were more concentrated in the
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FIG. 1. Live imaging of Golgi apparatus in mouse GV oocytes using
BODIPY-ceramide. Golgi apparatus of GV-arrested oocytes was labeled
with fluorescence-tagged ceramide and imaged using laser scanning con-
focal microscopy. Both cortical (A) and internal (B) focal planes are
shown. *Position of the germinal vesicle. Bar 5 20 mm.
FIG. 2. Golgi apparatus in mouse GV oocytes as visualized using b-
COP. Effect of energy deprivation. Golgi apparatus of GV-arrested oocytes
was labeled by immunocytochemistry using the b-COP antibody, in both
control oocytes (A) and oocytes placed in an energy-depleted medium
(B). A focal plane through the center of the oocyte is shown in each case.
The cortical distribution of cortical granules, observed with LCA-FITC, is
also shown for A and B (A9 and B9, respectively). Bar 5 20 mm.
FIG. 3. Golgi apparatus in rhesus monkey GV oocytes was imaged by
immunocytochemistry using both b-COP antibody (A) and an antigiantin
probe (B). Bar 5 20 mm.
interior of the oocyte (Fig. 1B), although they were also
present at the cortex (Fig. 1A). Staining on the oocyte sur-
face, observed as a halo, is the likely result of probe at-
tachment to remnants of the zona pellucida.
The nature of these mini-Golgis in mouse GV oocytes
was confirmed by immunocytochemistry using the well-
known Golgi marker b-COP, a protein that is also present
in COPI vesicle coats. In dbcAMP-arrested GV oocytes the
b-COP probe stained a large number of aggregates (Fig.
2A), similar to the structures labeled by BODIPY-ceramide,
and these structures were also less abundant closer to the
cortex (not shown). At this stage most cortical granules, as
detected by LCA-FITC staining, were found close to the
oocyte surface (Fig. 2B), with only a few present in the
interior (not shown). Maintenance of a b-COP staining pat-
tern in a dynamic Golgi apparatus is energy-dependent. In-
deed, if GV oocytes were placed for 20–30 min in an en-
ergy-depleted version of the M2 medium (see Materials
and Methods) containing dbcAMP, no distinct structures
were labeled by the Golgi marker (Fig. 2A9), although the
cortical granule distribution (Fig. 2B9) and DNA (not
shown) remained unchanged. Furthermore, this distribution
of mini-Golgi stacks in the ooplasm of GV-arrested oocytes
was not exclusive to the mouse, because similar structures
could be detected in rhesus monkey GV oocytes (Fig. 3),
using both b-COP (Fig. 3A) and giantin (Fig. 3B) as mark-
ers for the organelle, suggesting a general pattern common
to mammalian oocytes.
Brefeldin A Disrupts the Golgi Apparatus in Mouse
GV Oocytes
To determine whether the Golgi apparatus is functionally
active in GV-arrested mouse oocytes we incubated the oo-
cytes in M2 medium containing both dbcAMP and brefel-
din A (5–10 mM). This treatment resulted in visible and
reversible redistribution of b-COP into the ooplasm (data
not shown). However, it has been shown that brefeldin A
can induce the release of b-COP from the Golgi apparatus
into the cytoplasm of somatic cells without affecting redis-
tribution of the organelle to the endoplasmic reticulum.
Therefore, we decided to evaluate the integrity of the Golgi
apparatus using the transmembrane cis-Golgi marker gian-
tin, a protein that is present in both Golgi stacks and COPI
vesicle coats (Fig. 4, A–D). Whereas control GV oocytes
showed the same mini-Golgi pattern described above (Fig.
4A), the ooplasm of brefeldin A-treated oocytes had no
distinct structures, as evaluated using the antigiantin probe
(Fig. 4B). Given that in somatic cells the effect of brefeldin
A is reversible, we washed out the drug and allowed the
oocytes a 1-h recovery period in fresh dbcAMP-containing
M2 medium. Following recovery the Golgi aggregates were
again visible in the ooplasm, and were similar to those seen
in control samples (Fig. 4C). However, the disruptive effect
of brefeldin A on Golgi structure was prevented in oocytes
that had been previously injected with GTP-g-S, a nonhy-
drolyzable GTP analogue (Fig. 4D, compare with Fig. 4B).
In addition, incubation of GV oocytes with brefeldin A had
no effect on the surface pattern of cortical granules, as vi-
sualized using LCA-FITC (Fig. 4, E and F).
To confirm these observations of the effect of brefeldin
A on the Golgi apparatus we repeated the experiment using
confocal microscopy and a marker for the trans-Golgi net-
work, the integral membrane protein TGN38 (Fig. 5). In
control GV oocytes, large TGN38-positive structures were
visible, similar to the patterns detected with ceramide, b-
COP, and giantin (Fig. 5A). In this case it was possible to
determine that the large Golgi aggregates seemed to be 1–
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FIG. 4. Effect of brefeldin A on the Golgi apparatus and cortical granules
of mouse GV oocytes. The Golgi apparatus was imaged by immunocy-
tochemistry using an antigiantin probe, both before (A), and after, a 1-h
incubation in M2 medium containing both dbcAMP and 5 mM brefeldin
A (B). Following this incubation the drug was washed out and oocytes
were visualized after a 1- to 2-h recovery period in dbcAMP containing
M2 (C). The effect of brefeldin A was also evaluated in GV oocytes that
had previously been injected with a final ooplasmic concentration of 40
mM GTP-g-S (D). An equivalent focal plane through the center of the
oocyte is shown in each case. The effect of brefeldin A on the cortical
granule pattern at the surface of GV oocytes was also monitored using
LCA-FITC. E) Control oocyte kept in dbcAMP-containing M2 medium. F)
Oocyte imaged following a 1-h incubation in M2 medium containing
both dbcAMP and 5 mM brefeldin A. Bar 5 20 mm.
3 mm long (Fig. 5A9). Following brefeldin A treatment
these aggregates were no longer visible, and a punctated
pattern emerged, similar to that observed with giantin (Fig.
5, B and B9). When the oocytes were allowed to recover
in M2 medium lacking the fungal metabolite, larger Golgi
structures were again visible in the ooplasm (Fig. 5C), al-
though confocal microscopy allowed us to determine that
they were smaller than those present in control GV oocytes
(Fig. 5C9). However, we were able to establish that these
recovered oocytes progressed normally through IVM, and
were able to extrude the first polar body if placed in M2
medium lacking dbcAMP. First polar body extrusion took
place in 68.3% 6 4.0 SEM of control oocytes, and in
73.0% 6 6.2 SEM recovered oocytes (P . 0.05); by com-
parison, oocytes maintained in brefeldin A showed only a
2.7% 6 2.1 SEM rate of first polar body extrusion (P ,
0.001, relative to the other two groups). Subsequently, these
matured (recovered) oocytes could be parthogenetically ac-
tivated in the presence of 5% ethanol, similar to control
oocytes. Control oocytes showed a 65% 6 7.8 SEM acti-
vation rate, whereas in recovered oocytes that rate was 68%
6 5.5 SEM (P . 0.05). Taken together these results suggest
that the effect of brefeldin A on mouse GV oocytes is in-
deed fully reversible.
Brefeldin A Inhibits Mouse Oocyte IVM
Disruption of the Golgi apparatus in GV-arrested mouse
oocyte following brefeldin A treatment was reminiscent of
what takes place during normal IVM, triggered by placing
the oocytes in dbcAMP-free M2 medium (Fig. 6). In GV
oocytes, Golgi structures, as visualized using the giantin
antibody, are conspicuous in the ooplasm, which also fea-
tures a well-defined nucleopore-containing nuclear enve-
lope (Fig. 6A). At GVBD the nuclear envelope is disman-
tled, the chromosomes condense, and the mini-Golgis dis-
solve, showing an accumulation of dotted structures in the
central part of the oocyte (Fig. 6B). The Golgi fragments
spread more evenly throughout the oocyte in metaphase-I
(Fig. 6C), and this distribution is maintained following ex-
trusion of the first polar body in metaphase-II (Fig. 6D)
oocytes. It is curious that a slight accumulation of giantin-
positive structures was often detected at the spindle poles
in this case (Fig. 6D), similar to what has been described
for the mitotic spindle of somatic cells.
It is interesting that brefeldin A arrested mouse oocyte
IVM after the onset of GVBD, the stage during which Gol-
gi fragmentation takes place (Fig. 7). Although some ap-
parently healthy oocytes arrest at different stages of matu-
ration, even in control samples, the effect of brefeldin A
was evident, virtually abolishing the conclusion of IVM, as
assessed by first polar body extrusion. The concentration
dependency of this drug effect was quite abrupt. No statis-
tically significant changes were detected within a 0.5–50
nM range of concentrations, compared with control samples
obtained on the same day (Fig. 7). However, the effect was
maximal at 0.5 mM brefeldin A, and higher concentrations
had no further effect (Fig. 7). Imaging the DNA by fluo-
rescence microscopy showed no distinct metaphase I ar-
rangements in brefeldin A-arrested oocytes, although the
chromosomes were condensed (data not shown). The re-
versibility of this inhibition was dependent on the time of
incubation. Thus, when oocytes were incubated in M2 with
0.5 mM brefeldin A for up to 6 h they could still complete
first polar body extrusion, provided the drug was washed
out, and the incubation continued in brefeldin A-free M2
medium. The rate of first polar body extrusion in these
recovered oocyes was 69.7% 6 4.5 SEM, comparable to
the 71.9 6 2.3 SEM rate found in control occytes (P .
0.05).
DISCUSSION
The Golgi apparatus in mouse GV oocytes is well de-
veloped, and consists of a series of aggregates that can be
visualized dynamically using BODIPY-ceramide, and by
immunocytochemistry. These large structures likely corre-
spond to the series of Golgi stacks (or dictyosomes) de-
scribed in many previous works in mouse and hamster oo-
cytes using ultrastructural analysis by electron microscopy
[15, 16, 21, 22].
The Golgi stacks of both mouse and rhesus GV oocytes
clearly resemble the mini-Golgis described in somatic cells
after microtubule disruption induced by nocodazole treat-
ment [26]. It should be noted that, besides a microtubular
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FIG. 5. Confocal imaging of the Golgi
apparatus of mouse GV oocytes as affect-
ed by brefeldin A. The Golgi apparatus
was imaged by immunocytochemistry and
confocal microscopy using an antibody di-
rected against the trans-Golgi network pro-
tein TGN38. A, A9) Control. B, B9) Follow-
ing a 1-h incubation in M2 medium con-
taining both dbcAMP and 5 mM brefeldin
A. C, C9) Following a 1- to 2-h recovery
period in dbcAMP containing M2, after re-
moval of brefeldin A. Equivalent focal
planes through the center of the oocyte
are shown in each case. A9, B9 and C9
correspond to higher magnifications of A,
B, and C, respectively.
‘‘crown’’ surrounding the GV, no defined microtubule or-
ganization has been detected in the ooplasm of GV oocytes
[43, 44]. This may contribute to the fragmentation of the
Golgi apparatus observed in this study. The effect of no-
codazole on Golgi apparatus organization is believed to
mimic the fragmentation of this organelle during mitosis
[26]. Indeed, organelle reorganization is one of the hall-
marks of cell division, and during mitosis the cell must
guarantee that both daughter cells inherit similar amounts
of membrane-bound organelles [23]. In some cases, pri-
marily related to the endoplasmic reticulum and the Golgi
apparatus, this involves organelle fragmentation, with con-
comitant dissemination of vesicular fragments throughout
the cytoplasm, before cytokinesis. A more or less homo-
geneous distribution of these fragments in the cell ensures
that each daughter cell will receive approximately half the
available material [23]. However, although this stochastic
method seems to account for ER inheritance, other authors
have suggested that Golgi-derived fragments may interact
with the mitotic spindle, and that partitioning of the Golgi
apparatus may be more accurate than a random process
would predict [45, 46]. There are also conflicting theories
regarding what precisely is partitioned during mitosis.
Whereas some authors maintain that Golgi and ER partition
independently, others suggest that the Golgi collapses into
the ER at the onset of mitosis, and reforms from ER exit
sites only following telophase [24, 25]. Regardless, many
cellular events related to organelle inheritance, including
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FIG. 6. Golgi apparatus dynamics during
mouse oocyte in vitro maturation. The
Golgi apparatus of mouse oocytes was la-
beled by immunocytochemistry using the
giantin antibody (red) during several stages
of maturation. A) GV. B) GVBD. C) Meta-
phase I. D) Metaphase II. Green, nuclear
pore complexes; blue, DNA. Bar 5 20
mm.
FIG. 7. Effect of brefeldin A on the in vi-
tro maturation of mouse oocytes. Mouse
GV oocytes were placed in M2 medium
containing varying concentrations of bre-
feldin A, cultured overnight, and scored
the next morning as GV, GVBD, or polar
body I oocytes. The graph compiles the
data of 5 independent experiments in
which a total of 353 oocytes were ob-
served. The average 6 SEM is shown in
each case. The only significant differences
were detected with the two highest con-
centrations of brefeldin A, in relation to
the respective controls. *P , 0.01; **P ,
0.001.
Golgi fragmentation, also take place during meiosis [16, 21,
22, 47], although asymmetrical division, with concomitant
extrusion of polar bodies, limits the loss of precious ma-
terial from the future female gamete in this case.
Although the Golgi apparatus of somatic cells is frag-
mented following microtubule depolymerization, it can still
export proteins to the plasma membrane, albeit at a lower
rate [48]. Similarly, the mini-Golgis in GV oocytes are
functionally active, as attested by the energy dependence
of the b-COP staining patterns and sensitivity to brefeldin
A. In somatic cells this fungal metabolite inhibits protein
secretion by inhibiting ER-to-Golgi transport. At the mo-
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lecular level, brefeldin A acts directly on COPI coat re-
cruitment to membranes [28] via specific ADP-ribosylation
factor exchange factors [34, 49]. This results in blocking
of vesicle export, but not of Golgi-ER recycling, thus caus-
ing the Golgi apparatus to effectively fragment and collapse
into the ER. Indeed, we report similar observations in GV
oocytes. Incidentally, GTP-g-S, a nonhydrolyzable GTP an-
alogue, was able to block the effect of brefeldin A on GV
oocytes, suggesting the participation of a GTPase in this
process, as has been shown in somatic cells [50]. In addi-
tion, an inhibitory effect of injected GTP-g-S on mouse
oocyte IVM has been described [51].
Given that brefeldin A acts directly on the formation of
COPI-coated vesicles, it could be expected that the distri-
bution of b-COP and giantin, both included in COPI coats
[28, 52], is affected by the drug, as was indeed the case.
However, the effect of brefeldin A was similar when
TGN38, an integral trans-Golgi network-resident protein,
was used as a marker. Unlike Golgi stacks, which collapse
into the ER in the presence of the drug, the trans-Golgi
network forms independent fragments, that accumulate
close to the microtubule organizing center following bre-
feldin A treatment of somatic cells [53, 54]. That all three
probes yield similar results (i.e., a diffuse cytoplasmic
staining following brefeldin A treatment), leads us to con-
clude that the drug fragments the different regions of the
Golgi apparatus in mouse GV oocytes. Indeed, the concen-
tration of drug needed to disrupt the Golgi was comparable
to what has been described for somatic cells [33], and other
prominent oocyte structures, such as the cortical granules,
seemed unaffected by the treatment. The effect of brefeldin
A was fully reversible, and Golgi structures could be re-
formed if the drug was removed, as has been noted also in
somatic cells. Furthermore, recovered oocytes could pro-
ceed through IVM when dbcAMP inhibition was lifted.
Large Golgi elements, which are slightly more prevalent
in the interior of the oocyte at the GV stage, were replaced
with much smaller vesicular structures shortly after the on-
set of IVM. These vesicles seemed to concentrate at the
central part of the oocyte at the GVBD stage, and then
spread out into the ooplasm, maintaining a seemingly uni-
form cytoplasmic distribution throughout IVM, and in
metaphase II-arrested oocytes. It has been well established
that GV-stage oocytes undergo perinuclear aggregation of
organelles during GVBD. These include acidic, lysosome-
like organelles [19, 20] and mitochondria [17]; which later
disperse in the ooplasm as the first meiotic spindle migrates
to the oocyte periphery [20]. That we have made similar
observations with Golgi fragments is not unexpected, given
that Golgi cisternae have an acidic pH, and can be labeled
in vivo with probes directed to lysosomes [55]. These re-
sults seem to confirm that ooplasm reorganization at the
GVBD stage, including perinuclear aggregation of organ-
elles, is an important feature in meiotic progression, and
may play a functional role in maturation [19, 20]. In con-
trast, the ER has a loose network arrangement in mouse
GV oocytes, with few centrally located aggregates, and fol-
lowing IVM it localizes at the cortex, with numerous dense
accumulations, possibly related to a reorganization of cal-
cium stores prior to egg activation and cortical granule exo-
cytosis [18, 56].
Regulated secretion is inhibited during mitosis in so-
matic cells, and newly synthesized proteins are not deliv-
ered to the Golgi apparatus and the cell surface [57–59].
Protein secretion is also blocked during maturation in Xen-
opus oocytes [47]. However, in this case the block is down-
stream from the Golgi apparatus, because ER-to-Golgi and
cis to medial Golgi transport still take place in mature oo-
cytes [60, 61]. This may constitute a major difference be-
tween mitotic and meiotic division. It is interesting to note
that although protein secretion is blocked during meiotic
maturation, we have shown that brefeldin A is able to re-
versibly inhibit the IVM of mouse oocytes. It is also inter-
esting that the drug blocks mouse oocyte IVM at the same
stage at which it is arrested by protein synthesis inhibitors
[2–5]. This effect is likely to be mediated by the brefeldin
A-induced disruption of the Golgi apparatus, and ensuing
inhibition of membrane trafficking. It is curious that in Xen-
opus oocytes brefeldin A is able to trigger oocyte matura-
tion [62], although the concentration of drug necessary to
mimic progesterone-induced maturation was 10 times high-
er than what is required to affect mammalian somatic and
spermatogenic cells [33, 35, 36, 63]. This may reflect some
species-specific differences.
Nevertheless, our results suggest that, besides protein
synthesis, progression of murine oocyte maturation possibly
also requires functional membrane trafficking sometime af-
ter GVBD, resulting in either the modification of proteins
at the Golgi level, or the delivery of these proteins to ap-
propriate (post-Golgi) sites.
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